MC
HCAT icon

Martin & Co’s Health Catalyst HCAT Stock Holding History

Martin & Co’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-526,186
Closed -$668K – 101
2026
Q1 		$668K Buy
526,186
+13,033
+3% +$24.5K 0.11% 99
2025
Q4 		$1.23M Buy
513,153
+1,026
+0.2% +$2.81K 0.21% 91
2025
Q3 		$1.46M Buy
512,127
+2,967
+0.6% +$10.2K 0.26% 85
2025
Q2 		$1.92M Sell
509,160
-2,525
-0.5% -$9.93K 0.35% 75
2025
Q1 		$2.32M Buy
511,685
+20,687
+4% +$109K 0.45% 67
2024
Q4 		$3.47M Buy
490,998
+218,293
+80% +$1.74M 0.86% 42
2024
Q3 		$2.22M Buy
+272,705
New +$1.97M 0.52% 70

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Martin & Co's HCAT Position: Q2 2026 in Review

Martin & Co sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 526,186 shares — an estimated $668K sold.

Martin & Co first reported a position in HCAT in Q3 2024 and held it in 7 quarters. The position peaked at $3.47M in Q4 2024. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Martin & Co reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • Martin & Co sold 526,186 Health Catalyst shares in Q2 2026, an estimated $668K.
  • Martin & Co first reported a position in Health Catalyst in Q3 2024 and held it in 7 quarters.
  • Martin & Co's Health Catalyst position peaked at $3.47M in Q4 2024.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Martin & Co's 13F filing for Q2 2026, filed 12 Aug 2026.